These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28891717)

  • 1. Longitudinal Viral Suppression Among a Cohort of Adolescents and Young Adults with Behaviorally Acquired Human Immunodeficiency Virus.
    Wood SM; Lowenthal E; Lee S; Ratcliffe SJ; Dowshen N
    AIDS Patient Care STDS; 2017 Sep; 31(9):377-383. PubMed ID: 28891717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term virologic responses to antiretroviral therapy among HIV-positive patients entering adherence clubs in Khayelitsha, Cape Town, South Africa: a longitudinal analysis.
    Kehoe K; Boulle A; Tsondai PR; Euvrard J; Davies MA; Cornell M
    J Int AIDS Soc; 2020 May; 23(5):e25476. PubMed ID: 32406983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superior virologic and treatment outcomes when viral load is measured at 3 months compared to 6 months on antiretroviral therapy.
    Kerschberger B; Boulle AM; Kranzer K; Hilderbrand K; Schomaker M; Coetzee D; Goemaere E; Van Cutsem G
    J Int AIDS Soc; 2015; 18(1):20092. PubMed ID: 26403636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimen.
    Varriano B; Sandler I; Loutfy M; Steinberg S; Smith G; Kovacs C; Brunetta J; Fletcher D; Knox D; Merkley B; Chang B; Tilley D; Acsai M; Crouzat F
    Int J STD AIDS; 2019 Jun; 30(7):680-688. PubMed ID: 31042101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
    Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.
    Raboud J; Blitz S; Walmsley S; Thompson C; Rourke SB; Loutfy MR;
    HIV Clin Trials; 2010; 11(6):340-50. PubMed ID: 21239362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Postsuppression Virologic Rebound in Perinatally HIV-Infected Asian Adolescents on Stable Combination Antiretroviral Therapy.
    Sudjaritruk T; Aurpibul L; Ly PS; Le TPK; Bunupuradah T; Hansudewechakul R; Lumbiganon P; Chokephaibulkit K; Nik Yusoff NK; Nguyen LV; Mohd Razali KA; Fong MS; Nallusamy RA; Kurniati N; Do VC; Boettiger DC; Sohn AH; Kariminia A
    J Adolesc Health; 2017 Jul; 61(1):91-98. PubMed ID: 28343759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda.
    Castelnuovo B; Kiragga A; Mubiru F; Kambugu A; Kamya M; Reynolds SJ
    J Int AIDS Soc; 2016; 19(1):20773. PubMed ID: 27319742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation.
    Laprise C; de Pokomandy A; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Nov; 57(10):1489-96. PubMed ID: 23946221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent Low-level Viremia Predicts Subsequent Virologic Failure: Is It Time to Change the Third 90?
    Esber A; Polyak C; Kiweewa F; Maswai J; Owuoth J; Maganga L; Adamu Y; Hickey PW; Ake JA; Crowell TA
    Clin Infect Dis; 2019 Aug; 69(5):805-812. PubMed ID: 30462188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
    Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.
    Saracino A; Lorenzini P; Lo Caputo S; Girardi E; Castelli F; Bonfanti P; Rusconi S; Caramello P; Abrescia N; Mussini C; Monno L; d'Arminio Monforte A;
    Clin Microbiol Infect; 2016 Mar; 22(3):288.e1-8. PubMed ID: 26551839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of integrase strand transfer inhibitors among treatment-experienced patients in a clinical setting.
    Davy-Mendez T; Napravnik S; Zakharova O; Wohl DA; Farel CE; Eron JJ
    AIDS; 2019 Jun; 33(7):1187-1195. PubMed ID: 30870198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort.
    Paris D; Ledergerber B; Weber R; Jost J; Flepp M; Opravil M; Ruef C; Zimmerli S
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1631-8. PubMed ID: 10606086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of adherence, retention, and transition patterns of adolescents living with HIV in Nigeria.
    Meloni ST; Agaba P; Chang CA; Yiltok E; Oguche S; Ejeliogu E; Agbaji O; Okonkwo P; Kanki PJ
    PLoS One; 2020; 15(7):e0236801. PubMed ID: 32735566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-level outcomes and virologic suppression rates in HIV-infected patients receiving antiretroviral therapy in Rwanda.
    Riedel DJ; Stafford KA; Memiah P; Coker M; Baribwira C; Sebeza J; Karorero E; Nsanzimana S; Morales F; Redfield RR
    Int J STD AIDS; 2018 Aug; 29(9):861-872. PubMed ID: 29621951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologic outcome among patients receiving antiretroviral therapy at five hospitals in Haiti.
    Jean Louis F; Buteau J; François K; Hulland E; Domerçant JW; Yang C; Boncy J; Burris R; Pelletier V; Wagar N; Deyde V; Lowrance DW; Charles M
    PLoS One; 2018; 13(1):e0192077. PubMed ID: 29381736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
    Nachega JB; Hislop M; Dowdy DW; Gallant JE; Chaisson RE; Regensberg L; Maartens G
    AIDS; 2008 Oct; 22(16):2117-25. PubMed ID: 18832875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentre analysis of second-line antiretroviral treatment in HIV-infected children: adolescents at high risk of failure.
    Boerma RS; Bunupuradah T; Dow D; Fokam J; Kariminia A; Lehman D; Kityo C; Musiime V; Palumbo P; Schoffelen A; Sophan S; Zanoni B; Rinke de Wit TF; Calis JCJ; Sigaloff KCE;
    J Int AIDS Soc; 2017 Sep; 20(1):21930. PubMed ID: 28953325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.